PGHLPharmaceuticals
Procter & Gamble Health Ltd — Cash Flow Statement
₹4798.80
-1.61%
Procter & Gamble Health Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 206.56 Cr | 193.52 Cr | 131.60 Cr | 194.68 Cr |
| Capital Expenditure | -21.73 Cr | -42.48 Cr | -37.92 Cr | -52.58 Cr |
| End Cash Position | 238.73 Cr | 435.42 Cr | 319.40 Cr | 464.05 Cr |
| Other Cash Adjustment Outside Changein Cash | 0.01 Cr | -0.01 Cr | — | — |
| Beginning Cash Position | 435.42 Cr | 319.40 Cr | 464.05 Cr | 635.69 Cr |
| Changes In Cash | -196.69 Cr | 116.03 Cr | -144.65 Cr | -171.64 Cr |
| Financing Cash Flow | -418.11 Cr | -98.47 Cr | -288.63 Cr | -386.63 Cr |
| Cash Dividends Paid | -414.99 Cr | -93.79 Cr | -283.85 Cr | -381.78 Cr |
| Investing Cash Flow | -6.87 Cr | -21.50 Cr | -25.54 Cr | -32.27 Cr |
| Net Other Investing Changes | 2.24 Cr | 6.79 Cr | 2.50 Cr | 3.23 Cr |
| Interest Received Cfi | 12.62 Cr | 14.19 Cr | 9.88 Cr | 17.08 Cr |
| Net PPE Purchase And Sale | -21.73 Cr | -42.48 Cr | -37.92 Cr | -52.58 Cr |
| Purchase Of PPE | -21.73 Cr | -42.48 Cr | -37.92 Cr | -52.58 Cr |
| Operating Cash Flow | 228.29 Cr | 236.00 Cr | 169.52 Cr | 247.26 Cr |
| Taxes Refund Paid | -85.19 Cr | -89.66 Cr | -63.86 Cr | -68.12 Cr |
| Change In Working Capital | -12.12 Cr | -30.02 Cr | -47.30 Cr | 41.22 Cr |
| Change In Other Current Liabilities | -11.08 Cr | 3.21 Cr | 8.38 Cr | 0.56 Cr |
| Change In Other Current Assets | 18.27 Cr | -31.84 Cr | -22.01 Cr | -6.84 Cr |
| Change In Payable | -71.61 Cr | 63.92 Cr | -6.50 Cr | 1.81 Cr |
| Change In Inventory | 23.13 Cr | -32.39 Cr | -2.02 Cr | 11.47 Cr |
| Change In Receivables | 29.17 Cr | -32.92 Cr | -25.15 Cr | 34.22 Cr |
| Other Non Cash Items | -13.11 Cr | -15.61 Cr | -12.78 Cr | -16.35 Cr |
| Stock Based Compensation | 0.69 Cr | 0.56 Cr | 3.41 Cr | 1.93 Cr |
| Provisionand Write Offof Assets | -7.45 Cr | 5.17 Cr | -5.94 Cr | 8.14 Cr |
| Deferred Tax | 12.27 Cr | 14.31 Cr | — | 3.54 Cr |
| Depreciation And Amortization | 27.40 Cr | 28.10 Cr | 27.08 Cr | 30.04 Cr |
| Depreciation | 27.40 Cr | 28.10 Cr | 27.08 Cr | 30.04 Cr |
| Pension And Employee Benefit Expense | 7.05 Cr | -2.71 Cr | -1.38 Cr | 5.37 Cr |
| Net Foreign Currency Exchange Gain Loss | 2.02 Cr | 0.45 Cr | 3.46 Cr | 3.05 Cr |
| Gain Loss On Sale Of PPE | 0.51 Cr | -0.71 Cr | 0.54 Cr | 0.42 Cr |
| Net Income From Continuing Operations | 273.32 Cr | 314.20 Cr | 253.37 Cr | 233.28 Cr |
| Net Investment Purchase And Sale | — | — | — | 0.00 |
| Sale Of Investment | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Procter & Gamble Health Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.